Sunday, September 20, 2026 Evidence-led medical research news
The First Cohort
Medical research, with the receipts

conflict-of-interest

10 stories tagged "conflict-of-interest"

Cancer

The Mesothelioma Drug in This Month's Headlines Was Tested in Fifteen People

The scientist whose lab found the drug's target is also chief science officer of the company selling it, a conflict the breakthrough headlines tuck into a job title.

Autoimmune & Inflammation

Seven Biologics, Up to $47,000 a Year, and 89 Percent of Europe's Severe Asthmatics Still Aren't in Remission

The Lancet calls severe asthma an 'unmet need.' A 13,455-patient European registry shows most of those patients are already on the pricey biologics, and 89 percent still have active disease.

Cancer

Twenty People, No Control Arm, and a Startup on the Side: Reading the Pancreatic Cancer Vaccine's Fine Print

Ninety percent of twenty volunteers made KRAS-specific T cells. None was shown to avoid cancer. Two of the investigators co-founded the company that licensed the shot from Johns Hopkins, which stands to collect royalties.

Nutrition & Food

A PETA-Tied Doctors Group Is Suing to Kill RFK Jr.'s New Food Pyramid

The Physicians Committee says a secret, industry-tied panel redirected the 2025-2030 dietary guidelines. The group crying capture spent years inside PETA's funding orbit.

Cancer

UC Irvine's 'Framework' for Safer CAR-T Is a Hypothesis Essay, Not a Study

The senior author consults for Kite Pharma, whose Yescarta accounted for all 6 grade-5 neurotoxicity deaths in the cited review's real-world data, the exact harm the paper proposes to treat.

Infectious Disease

Eight Infant Macaques Showed No HIV Rebound for a Year. The Third Drug Comes From a Convicted-Fraud Biotech.

OHSU's triple regimen left no detectable virus in all eight infant macaques a year after treatment stopped, even after the harshest rebound test. Two of the authors hold a financial stake in the company behind the experimental third drug.

Investigations

A JAMA Essay Says the Doctor Makes Your Care Worse. Three of Its Four Authors Sell the AI.

The Viewpoint predicts autonomous AI will run much of primary care by 2030, and that adding a human doctor can make the care worse. Its evidence is trained actors chatting over text, and three of its four authors sell or bankroll the AI.

Nutrition & Food

The Study Telling You Not to Bother Cutting Sweet Foods Was Co-Funded by the Soda and Sweetener Industry

The Sweet Tooth Trial found no reason to reduce sweet-tasting foods. Its private funders include the soda industry's trade group and the International Sweeteners Association.

Nutrition & Food

Summer Sun Won't Save You: A Vitamin D Study Funded by the People Who Sell the Spray

A Newcastle screening study found vitamin D deficiency persists through summer in older and ethnic-minority adults in northern Britain. The funder sells the fix.

Nutrition & Food

Your Five-a-Day Isn't Enough Flavanols, Says the Company That Sells Them by the Capsule

A new study says following dietary guidelines won't get you enough flavanols for heart protection. Two of its authors work for the company that sells flavanols in a capsule.